Viewing Study NCT04511650


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2026-02-04 @ 3:00 AM
Study NCT ID: NCT04511650
Status: TERMINATED
Last Update Posted: 2023-06-08
First Post: 2020-08-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019
Sponsor: EyePoint Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
None Acute Respiratory Distress Syndrome (ARDS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None ARDS View
None Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) View